JPM19: A biotech's M&A invitation, Editas' next CRISPR step and more from day 3

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 10, 2019 at 12:32: PM
via Pharma can't have an $8 billion deal every day. That was evident Wednesday, as the buzz within the Westin St. Francis tapered off for the first time since the 37th annual J.P. Morgan Healthcare Conference began.

article source
 

<



Similar threads

cafead
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout &amp; More
Replies
0
Views
135
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM19: Spark looks at scale, manufacturing as gene therapy matures
Replies
0
Views
292
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Can the Fed’s rate cut change biotech’s ‘new normal’?
Replies
0
Views
1
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
With $3B funding round, Bain set to make more biotech bets
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote